ED
SHW icon

Exane Derivatives’s Sherwin-Williams SHW Stock Holding History

Exane Derivatives’s Portfolio SHW Stock Details SHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-240,777
Closed -$22.1M – 567
2015
Q2 		$22.1M Buy
240,777
+10,863
+5% +$1.03M 2.37% 21
2015
Q1 		$21.8M Buy
229,914
+74,052
+48% +$6.9M 2.41% 18
2014
Q4 		$13.7M Buy
+155,862
New +$12.3M 1.89% 6

Other funds holding SHW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Exane Derivatives's SHW Position: Q3 2015 in Review

Exane Derivatives sold out of Sherwin-Williams (SHW) in Q3 2015, closing a stake of 240,777 shares — an estimated $22.1M sold.

Exane Derivatives first reported a position in SHW in Q4 2014 and held it in 3 quarters. The position peaked at $22.1M in Q2 2015. 630 funds tracked by Wall St. Rank hold SHW as of Q3 2015.

  • Exane Derivatives reported no remaining Sherwin-Williams position as of Q3 2015 after selling out during the quarter.
  • Exane Derivatives sold 240,777 Sherwin-Williams shares in Q3 2015, an estimated $22.1M.
  • Exane Derivatives first reported a position in Sherwin-Williams in Q4 2014 and held it in 3 quarters.
  • Exane Derivatives's Sherwin-Williams position peaked at $22.1M in Q2 2015.
  • 630 funds tracked by Wall St. Rank held Sherwin-Williams as of Q3 2015.

Based on Exane Derivatives's 13F filing for Q3 2015, filed 13 Nov 2015.